JPWO2019232503A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019232503A5 JPWO2019232503A5 JP2020566230A JP2020566230A JPWO2019232503A5 JP WO2019232503 A5 JPWO2019232503 A5 JP WO2019232503A5 JP 2020566230 A JP2020566230 A JP 2020566230A JP 2020566230 A JP2020566230 A JP 2020566230A JP WO2019232503 A5 JPWO2019232503 A5 JP WO2019232503A5
- Authority
- JP
- Japan
- Prior art keywords
- receptor
- antigen
- cancer
- protein
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000427 antigen Substances 0.000 claims 58
- 108091007172 antigens Proteins 0.000 claims 58
- 102000038129 antigens Human genes 0.000 claims 58
- 102000005962 receptors Human genes 0.000 claims 33
- 108020003175 receptors Proteins 0.000 claims 33
- 229920001184 polypeptide Polymers 0.000 claims 31
- 210000004027 cells Anatomy 0.000 claims 29
- 201000011510 cancer Diseases 0.000 claims 27
- 206010028980 Neoplasm Diseases 0.000 claims 25
- -1 GFRalpha4 Proteins 0.000 claims 20
- 239000003814 drug Substances 0.000 claims 18
- 229940079593 drugs Drugs 0.000 claims 18
- 230000027455 binding Effects 0.000 claims 15
- 206010025650 Malignant melanoma Diseases 0.000 claims 14
- 201000010099 disease Diseases 0.000 claims 14
- 201000001441 melanoma Diseases 0.000 claims 14
- 229920000023 polynucleotide Polymers 0.000 claims 13
- 239000002157 polynucleotide Substances 0.000 claims 13
- 102000004169 proteins and genes Human genes 0.000 claims 13
- 108090000623 proteins and genes Proteins 0.000 claims 13
- 101700029306 ANG1 Proteins 0.000 claims 12
- 101700086219 DVA-1 Proteins 0.000 claims 12
- 102100013180 KDR Human genes 0.000 claims 12
- 101710030435 SLAMF7 Proteins 0.000 claims 12
- 102100017640 SLAMF7 Human genes 0.000 claims 12
- 206010039491 Sarcoma Diseases 0.000 claims 10
- 102100014610 FCAR Human genes 0.000 claims 9
- 101700041688 FCAR Proteins 0.000 claims 9
- 102100008382 FCRL5 Human genes 0.000 claims 9
- 101700031417 FCRL5 Proteins 0.000 claims 9
- 102000009465 Growth Factor Receptors Human genes 0.000 claims 9
- 108010009202 Growth Factor Receptors Proteins 0.000 claims 9
- 229940088597 Hormone Drugs 0.000 claims 9
- 102100000250 MPL Human genes 0.000 claims 9
- 108060005135 MPL Proteins 0.000 claims 9
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 claims 9
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 claims 9
- 101710026335 TP53 Proteins 0.000 claims 9
- 102100019730 TP53 Human genes 0.000 claims 9
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 claims 9
- 239000005556 hormone Substances 0.000 claims 9
- 230000002401 inhibitory effect Effects 0.000 claims 9
- 101700053901 CD248 Proteins 0.000 claims 8
- 102100000196 CD248 Human genes 0.000 claims 8
- 206010025323 Lymphomas Diseases 0.000 claims 8
- 206010025310 Other lymphomas Diseases 0.000 claims 8
- 239000003795 chemical substances by application Substances 0.000 claims 8
- 239000003112 inhibitor Substances 0.000 claims 8
- 101710010518 CLEC12A Proteins 0.000 claims 7
- 102100013153 CLEC12A Human genes 0.000 claims 7
- 210000001744 T-Lymphocytes Anatomy 0.000 claims 7
- FFILOTSTFMXQJC-QCFYAKGBSA-N (2R,4R,5S,6S)-2-[3-[(2S,3S,4R,6S)-6-[(2S,3R,4R,5S,6R)-5-[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(E)-3-hydroxy-2-(octadecanoylamino)octadec-4-enoxy]oxan-3-yl]oxy-3-hy Chemical compound O[C@@H]1[C@@H](O)[C@H](OCC(NC(=O)CCCCCCCCCCCCCCCCC)C(O)\C=C\CCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@@H]([C@@H](N)[C@H](O)C2)C(O)C(O)CO[C@]2(O[C@@H]([C@@H](N)[C@H](O)C2)C(O)C(O)CO)C(O)=O)C(O)=O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](CO)O1 FFILOTSTFMXQJC-QCFYAKGBSA-N 0.000 claims 6
- 102100001437 BST1 Human genes 0.000 claims 6
- 101700053225 BST1 Proteins 0.000 claims 6
- 102100019456 CD276 Human genes 0.000 claims 6
- 101700015421 CD276 Proteins 0.000 claims 6
- 102100005284 CTAG2 Human genes 0.000 claims 6
- 101700050838 CTAG2 Proteins 0.000 claims 6
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 6
- 102100007097 DCT Human genes 0.000 claims 6
- 102100010912 EPCAM Human genes 0.000 claims 6
- 102000033180 ERVK-6 Human genes 0.000 claims 6
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims 6
- 102100009984 FAP Human genes 0.000 claims 6
- 102100015545 FCGR2A Human genes 0.000 claims 6
- 101710044640 FCGR2A Proteins 0.000 claims 6
- 102100004573 FLT3 Human genes 0.000 claims 6
- 101700036477 FOLH1 Proteins 0.000 claims 6
- 102100008453 FOLH1 Human genes 0.000 claims 6
- 108091006011 G proteins Proteins 0.000 claims 6
- 102100006970 GPRC5D Human genes 0.000 claims 6
- 101710045409 GPRC5D Proteins 0.000 claims 6
- 102000030007 GTP-Binding Proteins Human genes 0.000 claims 6
- 108091000058 GTP-Binding Proteins Proteins 0.000 claims 6
- 102000018109 Glypican-3 Human genes 0.000 claims 6
- 108050007237 Glypican-3 Proteins 0.000 claims 6
- 241000701806 Human papillomavirus Species 0.000 claims 6
- 102100014263 IGF1R Human genes 0.000 claims 6
- 102100016016 IGLL1 Human genes 0.000 claims 6
- 101700077624 IGLL1 Proteins 0.000 claims 6
- 210000003734 Kidney Anatomy 0.000 claims 6
- 102100011552 LCK Human genes 0.000 claims 6
- 101700033896 LCK Proteins 0.000 claims 6
- 102100004887 LILRA2 Human genes 0.000 claims 6
- 101710002790 LILRA2 Proteins 0.000 claims 6
- 102100011003 LY6K Human genes 0.000 claims 6
- 101700026174 LY6K Proteins 0.000 claims 6
- 101700062805 LY75 Proteins 0.000 claims 6
- 102100011002 LY75 Human genes 0.000 claims 6
- 210000000265 Leukocytes Anatomy 0.000 claims 6
- 101700011681 PAX3 Proteins 0.000 claims 6
- 101700057981 PAX5 Proteins 0.000 claims 6
- 108091000081 Phosphotransferases Proteins 0.000 claims 6
- 102000001253 Protein Kinases Human genes 0.000 claims 6
- 108020004532 RAS Proteins 0.000 claims 6
- 102100007784 RHOC Human genes 0.000 claims 6
- 102100017729 ROR1 Human genes 0.000 claims 6
- 101710036428 ROR1 Proteins 0.000 claims 6
- 101710003940 SPA17 Proteins 0.000 claims 6
- 102100017511 SPN Human genes 0.000 claims 6
- 101710018229 SPN Proteins 0.000 claims 6
- 102100012317 TGM5 Human genes 0.000 claims 6
- 210000001550 Testis Anatomy 0.000 claims 6
- 102000003911 Thyrotropin receptors Human genes 0.000 claims 6
- 108090000253 Thyrotropin receptors Proteins 0.000 claims 6
- 102000013532 Uroplakin II Human genes 0.000 claims 6
- 108010065940 Uroplakin II Proteins 0.000 claims 6
- 241000700605 Viruses Species 0.000 claims 6
- 102100008060 WT1 Human genes 0.000 claims 6
- 101700062995 WT1 Proteins 0.000 claims 6
- 102100016902 XAGE1A Human genes 0.000 claims 6
- 101710034584 XAGE1B Proteins 0.000 claims 6
- 125000000539 amino acid group Chemical group 0.000 claims 6
- 150000001413 amino acids Chemical class 0.000 claims 6
- 108090001123 antibodies Proteins 0.000 claims 6
- 102000004965 antibodies Human genes 0.000 claims 6
- 108010051081 dopachrome isomerase Proteins 0.000 claims 6
- 108010072257 fibroblast activation protein alpha Proteins 0.000 claims 6
- 108010003374 fms-Like Tyrosine Kinase 3 Proteins 0.000 claims 6
- 239000000833 heterodimer Substances 0.000 claims 6
- 102000035501 human TERT protein Human genes 0.000 claims 6
- 108091005810 human TERT protein Proteins 0.000 claims 6
- 230000035772 mutation Effects 0.000 claims 6
- 108010073531 rhoC GTP-Binding Protein Proteins 0.000 claims 6
- 125000005630 sialyl group Chemical group 0.000 claims 6
- 230000004936 stimulating Effects 0.000 claims 6
- 108010058721 transglutaminase 5 Proteins 0.000 claims 6
- 102100011221 CTCFL Human genes 0.000 claims 5
- 101700024464 CTCFL Proteins 0.000 claims 5
- 108010001687 Enterotoxin Receptors Proteins 0.000 claims 5
- 102100007660 GUCY2C Human genes 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 206010000830 Acute leukaemia Diseases 0.000 claims 4
- 102000002029 Claudin Human genes 0.000 claims 4
- 108050009302 Claudin Proteins 0.000 claims 4
- 101700021338 LEC Proteins 0.000 claims 4
- 101700077545 LECC Proteins 0.000 claims 4
- 101700028499 LECG Proteins 0.000 claims 4
- 101700063913 LECT Proteins 0.000 claims 4
- 206010024324 Leukaemias Diseases 0.000 claims 4
- 102100003616 OR51E2 Human genes 0.000 claims 4
- 101710013186 OR51E2 Proteins 0.000 claims 4
- 101710034340 Os04g0173800 Proteins 0.000 claims 4
- 102100001544 PLAC1 Human genes 0.000 claims 4
- 108050005091 PLAC1 Proteins 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 4
- 230000002708 enhancing Effects 0.000 claims 4
- 101700036391 lecA Proteins 0.000 claims 4
- 230000002688 persistence Effects 0.000 claims 4
- 210000000130 stem cell Anatomy 0.000 claims 4
- RSGRJCGAOAMTET-BBELEOPTSA-N (2S,4S,5R,6R)-5-acetamido-2-[(2S,3R,4R,5S,6R)-5-[(2S,3R,4R,5R,6R)-3-acetamido-4-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2R,3S,4R Chemical compound O[C@@H]1[C@@H](O)[C@H](OC[C@@H]([C@H](O)/C=C/CCCCCCCCCCCCC)NC(C)=O)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O[C@H]3[C@H]([C@H](O)[C@H](O)[C@H](C)O3)O)[C@@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](CO)O1 RSGRJCGAOAMTET-BBELEOPTSA-N 0.000 claims 3
- LHWDRTXZYZBFET-YBFHIOIGSA-N (2S,4S,5R,6R)-5-acetamido-6-[(1S,2R)-2-[(2S,4S,5R,6R)-5-acetamido-2-carboxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy-1,3-dihydroxypropyl]-2-[(2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-6-[(E,2S,3R)-2-formamido-3-hydroxyoctadec-4-enoxy]-4,5-dihyd Chemical compound O[C@@H]1[C@@H](O)[C@H](OC[C@@H]([C@H](O)/C=C/CCCCCCCCCCCCC)NC=O)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@@H](CO)O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)C(O)=O)[C@@H](O)[C@@H](CO)O1 LHWDRTXZYZBFET-YBFHIOIGSA-N 0.000 claims 3
- 102100012490 ACRBP Human genes 0.000 claims 3
- 101700081017 ACRBP Proteins 0.000 claims 3
- 102100000097 ADGRE2 Human genes 0.000 claims 3
- 101710005032 ADGRE5 Proteins 0.000 claims 3
- 102100020523 ADGRE5 Human genes 0.000 claims 3
- 101700014023 AFP Proteins 0.000 claims 3
- 101700065995 AFP1 Proteins 0.000 claims 3
- 102100000105 AKAP4 Human genes 0.000 claims 3
- 101700022014 AKAP4 Proteins 0.000 claims 3
- 102100007529 ANKRD30A Human genes 0.000 claims 3
- 101710026735 ANKRD30A Proteins 0.000 claims 3
- 101700061082 ANPX Proteins 0.000 claims 3
- 101700082057 ANPY Proteins 0.000 claims 3
- 101700077278 ANTF Proteins 0.000 claims 3
- 102100007495 AR Human genes 0.000 claims 3
- 101700064281 ATP1 Proteins 0.000 claims 3
- 102000013563 Acid Phosphatase Human genes 0.000 claims 3
- 108010051457 Acid Phosphatase Proteins 0.000 claims 3
- 208000009956 Adenocarcinoma Diseases 0.000 claims 3
- 102100007327 BIRC7 Human genes 0.000 claims 3
- 101700012308 BIRC8 Proteins 0.000 claims 3
- 101710024841 BMPR1B Proteins 0.000 claims 3
- 102100009548 BMPR1B Human genes 0.000 claims 3
- 101710042656 BQ2027_MB1231C Proteins 0.000 claims 3
- 210000000601 Blood Cells Anatomy 0.000 claims 3
- 210000001185 Bone Marrow Anatomy 0.000 claims 3
- 102100016446 CCDC54 Human genes 0.000 claims 3
- 101710023968 CCDC54 Proteins 0.000 claims 3
- 102100020486 CCN4 Human genes 0.000 claims 3
- 101710013050 CCN4 Proteins 0.000 claims 3
- 101700024589 CCR4 Proteins 0.000 claims 3
- 102100005826 CD19 Human genes 0.000 claims 3
- 101700087100 CD19 Proteins 0.000 claims 3
- 101710031913 CD200R1 Proteins 0.000 claims 3
- 102100017975 CD200R1 Human genes 0.000 claims 3
- 102100000189 CD22 Human genes 0.000 claims 3
- 101700020617 CD22 Proteins 0.000 claims 3
- 108060001249 CD24 Proteins 0.000 claims 3
- 102100000197 CD24 Human genes 0.000 claims 3
- 101700000388 CD244 Proteins 0.000 claims 3
- 102100000188 CD244 Human genes 0.000 claims 3
- 102100007290 CD274 Human genes 0.000 claims 3
- 101710012053 CD274 Proteins 0.000 claims 3
- 101710018047 CD300LF Proteins 0.000 claims 3
- 102100018204 CD300LF Human genes 0.000 claims 3
- 102100016493 CD33 Human genes 0.000 claims 3
- 101700017647 CD33 Proteins 0.000 claims 3
- 108060001251 CD34 Proteins 0.000 claims 3
- 102100016492 CD34 Human genes 0.000 claims 3
- 102100003279 CD38 Human genes 0.000 claims 3
- 101700044948 CD38 Proteins 0.000 claims 3
- 108010058905 CD44v6 antigen Proteins 0.000 claims 3
- 101700002874 CD72 Proteins 0.000 claims 3
- 102100019446 CD72 Human genes 0.000 claims 3
- 108060001253 CD99 Proteins 0.000 claims 3
- 102100016532 CD99 Human genes 0.000 claims 3
- 102100005706 CDH17 Human genes 0.000 claims 3
- 101710032683 CDH17 Proteins 0.000 claims 3
- 101710032680 CDH19 Proteins 0.000 claims 3
- 102100005695 CDH6 Human genes 0.000 claims 3
- 101710035597 CDH6 Proteins 0.000 claims 3
- 102220423338 CDNF G12V Human genes 0.000 claims 3
- 101700041715 CGHR Proteins 0.000 claims 3
- 101710026434 CLECL1 Proteins 0.000 claims 3
- 102100003505 CLECL1 Human genes 0.000 claims 3
- 102100017099 CNOT6 Human genes 0.000 claims 3
- 101700078818 CNOT6 Proteins 0.000 claims 3
- 102100005193 CSF2RA Human genes 0.000 claims 3
- 101710008988 CSF2RA Proteins 0.000 claims 3
- 102100001891 CTAG1A Human genes 0.000 claims 3
- 101710004449 CTAG1A Proteins 0.000 claims 3
- 102000013392 Carboxylesterase Human genes 0.000 claims 3
- 108010051152 Carboxylesterase Proteins 0.000 claims 3
- 210000000349 Chromosomes Anatomy 0.000 claims 3
- 102000018832 Cytochromes Human genes 0.000 claims 3
- 108010052832 Cytochromes Proteins 0.000 claims 3
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 claims 3
- 102100007913 DCHS1 Human genes 0.000 claims 3
- 101710036889 DCHS1 Proteins 0.000 claims 3
- 102100013694 DLL3 Human genes 0.000 claims 3
- 101700003144 DLL3 Proteins 0.000 claims 3
- 101700058212 DSG3 Proteins 0.000 claims 3
- 101700014897 Dsg1a Proteins 0.000 claims 3
- 102000003425 EC 1.14.18.1 Human genes 0.000 claims 3
- 108060008724 EC 1.14.18.1 Proteins 0.000 claims 3
- 102100014127 EEF2 Human genes 0.000 claims 3
- 102100011168 EFNB2 Human genes 0.000 claims 3
- 102100016627 EPHA2 Human genes 0.000 claims 3
- 101700025368 ERBB2 Proteins 0.000 claims 3
- 102100016662 ERBB2 Human genes 0.000 claims 3
- 101710038044 ERVK-6 Proteins 0.000 claims 3
- 101710027967 ERVW-1 Proteins 0.000 claims 3
- 101710007023 ESAG4 Proteins 0.000 claims 3
- 108010055196 EphA2 Receptor Proteins 0.000 claims 3
- 108010044090 Ephrin-B2 Proteins 0.000 claims 3
- 102100012318 F3 Human genes 0.000 claims 3
- 101710044641 FCGR2B Proteins 0.000 claims 3
- 101710044642 FCGR2C Proteins 0.000 claims 3
- 102000006815 Folate receptors Human genes 0.000 claims 3
- 108020005243 Folate receptors Proteins 0.000 claims 3
- 108090000123 Fos-related antigen 1 Proteins 0.000 claims 3
- 102000003817 Fos-related antigen 1 Human genes 0.000 claims 3
- 102100010054 GAD1 Human genes 0.000 claims 3
- 102100011455 GPA33 Human genes 0.000 claims 3
- 101700064037 GPA33 Proteins 0.000 claims 3
- 101700040370 GPNMB Proteins 0.000 claims 3
- 206010018075 Generalised anxiety disease Diseases 0.000 claims 3
- 102000003886 Glycoproteins Human genes 0.000 claims 3
- 108090000288 Glycoproteins Proteins 0.000 claims 3
- 102100020458 HLA-A Human genes 0.000 claims 3
- 108010075704 HLA-A Antigens Proteins 0.000 claims 3
- 102000026088 HLA-A2 Antigen Human genes 0.000 claims 3
- 108010074032 HLA-A2 Antigen Proteins 0.000 claims 3
- 102100020459 HLA-B Human genes 0.000 claims 3
- 108010058607 HLA-B Antigens Proteins 0.000 claims 3
- 102100020457 HLA-C Human genes 0.000 claims 3
- 108010052199 HLA-C Antigens Proteins 0.000 claims 3
- 102100005784 HLA-DOA Human genes 0.000 claims 3
- 101710007992 HLA-DOA Proteins 0.000 claims 3
- 102100005785 HLA-DOB Human genes 0.000 claims 3
- 101710007991 HLA-DOB Proteins 0.000 claims 3
- 108010010378 HLA-DP Antigens Proteins 0.000 claims 3
- 102000015789 HLA-DP Antigens Human genes 0.000 claims 3
- 108010062347 HLA-DQ Antigens Proteins 0.000 claims 3
- 108010058597 HLA-DR Antigens Proteins 0.000 claims 3
- 102000006354 HLA-DR Antigens Human genes 0.000 claims 3
- 102100003404 HLA-G Human genes 0.000 claims 3
- 108010024164 HLA-G Antigens Proteins 0.000 claims 3
- 101710018261 HSP70-2 Proteins 0.000 claims 3
- 101710006492 HSPA2 Proteins 0.000 claims 3
- 241000709721 Hepatovirus A Species 0.000 claims 3
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims 3
- 101700021747 IGE Proteins 0.000 claims 3
- 108010031794 IGF Type 1 Receptor Proteins 0.000 claims 3
- 101700025802 IGF1R Proteins 0.000 claims 3
- 102100004549 IL13RA2 Human genes 0.000 claims 3
- 101710034342 IL13RA2 Proteins 0.000 claims 3
- 101700031172 IP5P5 Proteins 0.000 claims 3
- 101700025474 ISP2 Proteins 0.000 claims 3
- 102000004553 Interleukin-11 Receptors Human genes 0.000 claims 3
- 108010017521 Interleukin-11 Receptors Proteins 0.000 claims 3
- 102100011337 KLK4 Human genes 0.000 claims 3
- 101710036390 KLRK1 Proteins 0.000 claims 3
- 102100012223 KLRK1 Human genes 0.000 claims 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N L-serine Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 3
- 102100004400 L1CAM Human genes 0.000 claims 3
- 101700039980 L1CAM Proteins 0.000 claims 3
- 102100005918 LAMP1 Human genes 0.000 claims 3
- 102100004652 LGALS8 Human genes 0.000 claims 3
- 101710015832 LGALS8 Proteins 0.000 claims 3
- 101700006721 LMP2 Proteins 0.000 claims 3
- 108010009254 Lysosomal-Associated Membrane Protein 1 Proteins 0.000 claims 3
- 108060004726 MERTK Proteins 0.000 claims 3
- 102100018198 MMP16 Human genes 0.000 claims 3
- 101700013081 MMP16 Proteins 0.000 claims 3
- 101700007600 MOK Proteins 0.000 claims 3
- 102100018023 MOK Human genes 0.000 claims 3
- 102100000165 MS4A1 Human genes 0.000 claims 3
- 101710010909 MS4A1 Proteins 0.000 claims 3
- 102100015262 MYC Human genes 0.000 claims 3
- 101700075357 MYC Proteins 0.000 claims 3
- 102100018882 MYCN Human genes 0.000 claims 3
- 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 claims 3
- 108091008108 Myc family Proteins 0.000 claims 3
- 108010010748 N-Myc Proto-Oncogene Protein Proteins 0.000 claims 3
- 101700014192 NOCT Proteins 0.000 claims 3
- 206010029260 Neuroblastoma Diseases 0.000 claims 3
- 102100004939 PDGFRB Human genes 0.000 claims 3
- 102100003725 PLXDC1 Human genes 0.000 claims 3
- 101710008671 PLXDC1 Proteins 0.000 claims 3
- 102100005774 PRSS21 Human genes 0.000 claims 3
- 101710036249 PRSS21 Proteins 0.000 claims 3
- 102100018285 PSMB9 Human genes 0.000 claims 3
- 101710033536 PSMB9 Proteins 0.000 claims 3
- 102100004042 PTK7 Human genes 0.000 claims 3
- 101700007351 PTK7 Proteins 0.000 claims 3
- 108091005771 Peptidases Proteins 0.000 claims 3
- 108010077519 Peptide Elongation Factor 2 Proteins 0.000 claims 3
- 108010051742 Platelet-Derived Growth Factor beta Receptor Proteins 0.000 claims 3
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 3
- 210000002307 Prostate Anatomy 0.000 claims 3
- 239000004365 Protease Substances 0.000 claims 3
- 101700058902 RORA Proteins 0.000 claims 3
- 241000700159 Rattus Species 0.000 claims 3
- 101710042981 SHMT1 Proteins 0.000 claims 3
- 101710030439 SLAMF6 Proteins 0.000 claims 3
- 102100017641 SLAMF6 Human genes 0.000 claims 3
- 102100010114 SLC39A6 Human genes 0.000 claims 3
- 101710017109 SLC39A6 Proteins 0.000 claims 3
- 102100002063 SLC45A3 Human genes 0.000 claims 3
- 102100018827 SPA17 Human genes 0.000 claims 3
- 102100004865 SSX2 Human genes 0.000 claims 3
- 101700030927 SSX2 Proteins 0.000 claims 3
- 101710009474 STEAP1 Proteins 0.000 claims 3
- 102100006460 STEAP1 Human genes 0.000 claims 3
- 101710023234 Segment 5 Proteins 0.000 claims 3
- 241001522306 Serinus serinus Species 0.000 claims 3
- 102000018075 Subfamily B ATP Binding Cassette Transporter Human genes 0.000 claims 3
- 101800001271 Surface protein Proteins 0.000 claims 3
- 102100018484 TACSTD2 Human genes 0.000 claims 3
- 101710024898 TACSTD2 Proteins 0.000 claims 3
- 102100005491 TDGF1 Human genes 0.000 claims 3
- 101700073629 TDGF1 Proteins 0.000 claims 3
- 101710037124 TEK Proteins 0.000 claims 3
- 101700039171 TEM1 Proteins 0.000 claims 3
- 102100011827 TMPRSS2 Human genes 0.000 claims 3
- 101710044694 TMPRSS2 Proteins 0.000 claims 3
- 101710030862 TNFRSF13C Proteins 0.000 claims 3
- 102100009743 TNFRSF13C Human genes 0.000 claims 3
- 101710040533 TNFRSF8 Proteins 0.000 claims 3
- 102100009538 TNFRSF8 Human genes 0.000 claims 3
- 102100000184 TRIM26 Human genes 0.000 claims 3
- 101710021280 TRIM26 Proteins 0.000 claims 3
- 101710037528 TRX5 Proteins 0.000 claims 3
- 102000004591 Telomerase Human genes 0.000 claims 3
- 108010017842 Telomerase Proteins 0.000 claims 3
- 108010000499 Thromboplastin Proteins 0.000 claims 3
- 208000007536 Thrombosis Diseases 0.000 claims 3
- 108060008683 Tumor Necrosis Factor Receptors Proteins 0.000 claims 3
- 102000003298 Tumor Necrosis Factor Receptors Human genes 0.000 claims 3
- 102100015929 UPK1B Human genes 0.000 claims 3
- 101700064263 UPK1B Proteins 0.000 claims 3
- 101710036075 VSIR Proteins 0.000 claims 3
- 102100015314 VSIR Human genes 0.000 claims 3
- 210000001766 X Chromosome Anatomy 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- 201000005510 acute lymphocytic leukemia Diseases 0.000 claims 3
- 101710004777 afgp8 Proteins 0.000 claims 3
- 108010080146 androgen receptors Proteins 0.000 claims 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 3
- 229960002685 biotin Drugs 0.000 claims 3
- 235000020958 biotin Nutrition 0.000 claims 3
- 239000011616 biotin Substances 0.000 claims 3
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium monoxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims 3
- 102000008395 cell adhesion mediator activity proteins Human genes 0.000 claims 3
- 108040002558 cell adhesion mediator activity proteins Proteins 0.000 claims 3
- 230000011748 cell maturation Effects 0.000 claims 3
- 108040005514 choriogonadotropin hormone receptor activity proteins Proteins 0.000 claims 3
- 230000004069 differentiation Effects 0.000 claims 3
- 201000008325 diseases of cellular proliferation Diseases 0.000 claims 3
- 101700040883 dnaK2 Proteins 0.000 claims 3
- 230000001605 fetal Effects 0.000 claims 3
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims 3
- 230000003325 follicular Effects 0.000 claims 3
- 125000002446 fucosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)[C@@H](O1)C)* 0.000 claims 3
- 230000004927 fusion Effects 0.000 claims 3
- 102000037240 fusion proteins Human genes 0.000 claims 3
- 108020001507 fusion proteins Proteins 0.000 claims 3
- 108060004612 gad Proteins 0.000 claims 3
- 102000011778 gamma-delta T-Cell Antigen Receptors Human genes 0.000 claims 3
- 108010062214 gamma-delta T-Cell Antigen Receptors Proteins 0.000 claims 3
- PFJKOHUKELZMLE-VEUXDRLPSA-N ganglioside GM3 Chemical compound O[C@@H]1[C@@H](O)[C@H](OC[C@@H]([C@H](O)/C=C/CCCCCCCCCCCCC)NC(=O)CCCCCCCCCCCCC\C=C/CCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 PFJKOHUKELZMLE-VEUXDRLPSA-N 0.000 claims 3
- 230000000762 glandular Effects 0.000 claims 3
- 125000003147 glycosyl group Chemical group 0.000 claims 3
- 230000003394 haemopoietic Effects 0.000 claims 3
- 201000005787 hematologic cancer Diseases 0.000 claims 3
- 101700024633 ibp Proteins 0.000 claims 3
- 210000002865 immune cell Anatomy 0.000 claims 3
- 230000036039 immunity Effects 0.000 claims 3
- 200000000003 influenza A Diseases 0.000 claims 3
- 102000006495 integrins Human genes 0.000 claims 3
- 108010044426 integrins Proteins 0.000 claims 3
- 210000002570 interstitial cell Anatomy 0.000 claims 3
- 230000000968 intestinal Effects 0.000 claims 3
- 108010024383 kallikrein 4 Proteins 0.000 claims 3
- 101710043524 lpp2128 Proteins 0.000 claims 3
- 102000006240 membrane receptors Human genes 0.000 claims 3
- 108020004084 membrane receptors Proteins 0.000 claims 3
- 102000003735 mesothelin Human genes 0.000 claims 3
- 108090000015 mesothelin Proteins 0.000 claims 3
- 210000003867 nerve cell Anatomy 0.000 claims 3
- 210000002569 neurons Anatomy 0.000 claims 3
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims 3
- 108010079891 prostein Proteins 0.000 claims 3
- 101700032180 psaA Proteins 0.000 claims 3
- 101710038532 rpl44e Proteins 0.000 claims 3
- 101710026914 AAG Proteins 0.000 claims 2
- 101700009767 BRD4 Proteins 0.000 claims 2
- 210000003169 Central Nervous System Anatomy 0.000 claims 2
- 102000019034 Chemokines Human genes 0.000 claims 2
- 108010012236 Chemokines Proteins 0.000 claims 2
- 102000011045 Chloride Channels Human genes 0.000 claims 2
- 108010062745 Chloride Channels Proteins 0.000 claims 2
- 206010008958 Chronic lymphocytic leukaemia Diseases 0.000 claims 2
- 108050006400 Cyclins Proteins 0.000 claims 2
- 102000004127 Cytokines Human genes 0.000 claims 2
- 108090000695 Cytokines Proteins 0.000 claims 2
- ZBNZXTGUTAYRHI-UHFFFAOYSA-N Dasatinib Chemical compound C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1Cl ZBNZXTGUTAYRHI-UHFFFAOYSA-N 0.000 claims 2
- 210000004443 Dendritic Cells Anatomy 0.000 claims 2
- 230000035693 Fab Effects 0.000 claims 2
- 101710015954 HVA1 Proteins 0.000 claims 2
- 206010020243 Hodgkin's disease Diseases 0.000 claims 2
- 102000018358 Immunoglobulins Human genes 0.000 claims 2
- 108060003951 Immunoglobulins Proteins 0.000 claims 2
- 239000002067 L01XE06 - Dasatinib Substances 0.000 claims 2
- 101700065814 LEA2 Proteins 0.000 claims 2
- 101700048515 LEC1 Proteins 0.000 claims 2
- 101700046135 LEC2 Proteins 0.000 claims 2
- 101700028593 LECH Proteins 0.000 claims 2
- 208000000429 Leukemia, Lymphocytic, Chronic, B-Cell Diseases 0.000 claims 2
- 102100012240 MGAT5 Human genes 0.000 claims 2
- 210000002540 Macrophages Anatomy 0.000 claims 2
- 210000001616 Monocytes Anatomy 0.000 claims 2
- 206010029592 Non-Hodgkin's lymphomas Diseases 0.000 claims 2
- 102100007880 PCNA Human genes 0.000 claims 2
- 208000009052 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 2
- 206010038038 Rectal cancer Diseases 0.000 claims 2
- 102000037135 SLC34 Human genes 0.000 claims 2
- 108091006166 SLC34 Proteins 0.000 claims 2
- 108010070144 Single-Chain Antibodies Proteins 0.000 claims 2
- 102000005632 Single-Chain Antibodies Human genes 0.000 claims 2
- 210000001635 Urinary Tract Anatomy 0.000 claims 2
- 206010046766 Uterine cancer Diseases 0.000 claims 2
- 239000003449 adenosine A2 receptor antagonist Substances 0.000 claims 2
- 239000002467 adenosine A2a receptor antagonist Substances 0.000 claims 2
- 239000000853 adhesive Substances 0.000 claims 2
- 230000001070 adhesive Effects 0.000 claims 2
- 239000000910 agglutinin Substances 0.000 claims 2
- 108010034034 alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferase Proteins 0.000 claims 2
- 102000003859 claudin 6 Human genes 0.000 claims 2
- 108090000229 claudin 6 Proteins 0.000 claims 2
- 230000001086 cytosolic Effects 0.000 claims 2
- 229960002448 dasatinib Drugs 0.000 claims 2
- 239000000539 dimer Substances 0.000 claims 2
- 201000003444 follicular lymphoma Diseases 0.000 claims 2
- 239000002523 lectin Substances 0.000 claims 2
- 101700001016 mbhA Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical group 0.000 claims 2
- 239000003934 phosphoprotein phosphatase inhibitor Substances 0.000 claims 2
- 239000003757 phosphotransferase inhibitor Substances 0.000 claims 2
- 230000035755 proliferation Effects 0.000 claims 2
- 201000001275 rectum cancer Diseases 0.000 claims 2
- 210000003289 regulatory T cell Anatomy 0.000 claims 2
- 231100000486 side effect Toxicity 0.000 claims 2
- 230000035943 smell Effects 0.000 claims 2
- 239000008279 sol Substances 0.000 claims 2
- 230000004083 survival Effects 0.000 claims 2
- 230000001225 therapeutic Effects 0.000 claims 2
- 229920000160 (ribonucleotides)n+m Polymers 0.000 claims 1
- 208000003200 Adenoma Diseases 0.000 claims 1
- 208000004736 B-Cell Leukemia Diseases 0.000 claims 1
- 210000003719 B-Lymphocytes Anatomy 0.000 claims 1
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 206010005949 Bone cancer Diseases 0.000 claims 1
- 206010006143 Brain stem glioma Diseases 0.000 claims 1
- 102100011232 CTCF Human genes 0.000 claims 1
- 101700077477 CTCF Proteins 0.000 claims 1
- 206010007953 Central nervous system lymphoma Diseases 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 206010008943 Chronic leukaemia Diseases 0.000 claims 1
- 229920001405 Coding region Polymers 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 206010012818 Diffuse large B-cell lymphoma Diseases 0.000 claims 1
- 210000001671 Embryonic Stem Cells Anatomy 0.000 claims 1
- 206010014733 Endometrial cancer Diseases 0.000 claims 1
- 206010061850 Extranodal marginal zone B-cell lymphoma (MALT type) Diseases 0.000 claims 1
- 210000000416 Exudates and Transudates Anatomy 0.000 claims 1
- 101700086859 FER Proteins 0.000 claims 1
- 206010017758 Gastric cancer Diseases 0.000 claims 1
- 210000003958 Hematopoietic Stem Cells Anatomy 0.000 claims 1
- 201000006743 Hodgkin's lymphoma Diseases 0.000 claims 1
- 208000007766 Kaposi Sarcoma Diseases 0.000 claims 1
- 210000000822 Killer Cells, Natural Anatomy 0.000 claims 1
- 241000713666 Lentivirus Species 0.000 claims 1
- 210000004072 Lung Anatomy 0.000 claims 1
- 208000006557 Lymphoma, B-Cell, Marginal Zone Diseases 0.000 claims 1
- 206010061232 Lymphoproliferative disease Diseases 0.000 claims 1
- 201000003791 MALT lymphoma Diseases 0.000 claims 1
- 206010026798 Mantle cell lymphomas Diseases 0.000 claims 1
- 208000002030 Merkel Cell Carcinoma Diseases 0.000 claims 1
- 206010061289 Metastatic neoplasm Diseases 0.000 claims 1
- 206010028570 Myelopathy Diseases 0.000 claims 1
- 102100000565 NECTIN4 Human genes 0.000 claims 1
- 101710005664 NECTIN4 Proteins 0.000 claims 1
- 210000000581 Natural Killer T-Cells Anatomy 0.000 claims 1
- 206010029266 Neuroendocrine carcinoma of the skin Diseases 0.000 claims 1
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 240000007019 Oxalis corniculata Species 0.000 claims 1
- 208000008443 Pancreatic Carcinoma Diseases 0.000 claims 1
- 206010034299 Penile cancer Diseases 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 208000007525 Plasmablastic Lymphoma Diseases 0.000 claims 1
- 208000007541 Preleukemia Diseases 0.000 claims 1
- 208000006265 Renal Cell Carcinoma Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 102100005556 SLC34A2 Human genes 0.000 claims 1
- 108091006491 SLC34A2 Proteins 0.000 claims 1
- 210000003491 Skin Anatomy 0.000 claims 1
- 206010061367 Spinal cord disease Diseases 0.000 claims 1
- 206010041823 Squamous cell carcinoma Diseases 0.000 claims 1
- 206010042971 T-cell lymphoma Diseases 0.000 claims 1
- 206010057644 Testis cancer Diseases 0.000 claims 1
- 102000004357 Transferases Human genes 0.000 claims 1
- 108090000992 Transferases Proteins 0.000 claims 1
- 206010046885 Vaginal cancer Diseases 0.000 claims 1
- 206010047802 Waldenstrom's macroglobulinaemias Diseases 0.000 claims 1
- 201000005188 adrenal gland cancer Diseases 0.000 claims 1
- 230000000735 allogeneic Effects 0.000 claims 1
- 230000033115 angiogenesis Effects 0.000 claims 1
- 230000000890 antigenic Effects 0.000 claims 1
- 201000009030 carcinoma Diseases 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 230000001684 chronic Effects 0.000 claims 1
- 201000006934 chronic myeloid leukemia Diseases 0.000 claims 1
- 238000002648 combination therapy Methods 0.000 claims 1
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims 1
- 230000002124 endocrine Effects 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- 201000009277 hairy cell leukemia Diseases 0.000 claims 1
- 201000010536 head and neck cancer Diseases 0.000 claims 1
- 102000025599 immune receptors Human genes 0.000 claims 1
- 108091008191 immune receptors Proteins 0.000 claims 1
- 201000002313 intestinal cancer Diseases 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 230000003902 lesions Effects 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 201000000564 macroglobulinemia Diseases 0.000 claims 1
- 230000003211 malignant Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 201000007924 marginal zone B-cell lymphoma Diseases 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 230000001394 metastastic Effects 0.000 claims 1
- 239000000178 monomer Substances 0.000 claims 1
- 201000009251 multiple myeloma Diseases 0.000 claims 1
- 201000003793 myelodysplastic syndrome Diseases 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 230000000849 parathyroid Effects 0.000 claims 1
- 210000001778 pluripotent stem cell Anatomy 0.000 claims 1
- 201000007444 renal pelvis carcinoma Diseases 0.000 claims 1
- 238000007493 shaping process Methods 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 201000010874 syndrome Diseases 0.000 claims 1
- 201000003120 testicular cancer Diseases 0.000 claims 1
- 201000002510 thyroid cancer Diseases 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
- 241001430294 unidentified retrovirus Species 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024039934A JP2024073564A (ja) | 2018-06-01 | 2024-03-14 | 細胞療法のための多様な抗原結合ドメイン、新規プラットフォームおよびその他の強化 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862679741P | 2018-06-01 | 2018-06-01 | |
| US62/679,741 | 2018-06-01 | ||
| PCT/US2019/035096 WO2019232503A1 (en) | 2018-06-01 | 2019-06-01 | Diverse antigen binding domains, novel platforms and other enhancements for cellular therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024039934A Division JP2024073564A (ja) | 2018-06-01 | 2024-03-14 | 細胞療法のための多様な抗原結合ドメイン、新規プラットフォームおよびその他の強化 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021525509A JP2021525509A (ja) | 2021-09-27 |
| JPWO2019232503A5 true JPWO2019232503A5 (ko) | 2022-06-07 |
Family
ID=68697132
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566230A Pending JP2021525509A (ja) | 2018-06-01 | 2019-06-01 | 細胞療法のための多様な抗原結合ドメイン、新規プラットフォームおよびその他の強化 |
| JP2024039934A Pending JP2024073564A (ja) | 2018-06-01 | 2024-03-14 | 細胞療法のための多様な抗原結合ドメイン、新規プラットフォームおよびその他の強化 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024039934A Pending JP2024073564A (ja) | 2018-06-01 | 2024-03-14 | 細胞療法のための多様な抗原結合ドメイン、新規プラットフォームおよびその他の強化 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20210137977A1 (ko) |
| EP (1) | EP3802822A4 (ko) |
| JP (2) | JP2021525509A (ko) |
| KR (1) | KR20210057705A (ko) |
| CN (1) | CN113286879A (ko) |
| AU (1) | AU2019279084A1 (ko) |
| BR (1) | BR112020024246A2 (ko) |
| CA (1) | CA3101510A1 (ko) |
| CO (1) | CO2020016586A2 (ko) |
| EA (1) | EA202092945A1 (ko) |
| IL (1) | IL279100A (ko) |
| MX (1) | MX2020012927A (ko) |
| SG (1) | SG11202011837UA (ko) |
| TW (1) | TW202018083A (ko) |
| WO (1) | WO2019232503A1 (ko) |
| ZA (1) | ZA202007393B (ko) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018225732A1 (ja) | 2017-06-05 | 2018-12-13 | 国立大学法人三重大学 | Ｍａｇｅ－ａ４由来ペプチドを認識する抗原結合性タンパク質 |
| KR20200071079A (ko) * | 2017-09-27 | 2020-06-18 | 유니버시티 오브 써던 캘리포니아 | 공동-자극을 위한 신규한 플랫폼, 신규한 car 설계 및 입양 세포 치료를 위한 다른 향상 |
| SG11202105093RA (en) * | 2018-12-21 | 2021-06-29 | Hoffmann La Roche | Tumor-targeted agonistic cd28 antigen binding molecules |
| EP3733707A1 (en) * | 2019-04-30 | 2020-11-04 | Celyad S.A. | Car t-cells targeting bcma and uses thereof |
| EP3842461A1 (en) * | 2019-12-23 | 2021-06-30 | Albert-Ludwigs-Universität Freiburg | Chimeric antigen receptors that bind to prostate specific membrane antigen |
| JP2023509766A (ja) * | 2020-01-08 | 2023-03-09 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | Ｃｄ７０陽性腫瘍を標的化するようにナチュラルキラー細胞を操作する方法 |
| KR20230009386A (ko) * | 2020-04-10 | 2023-01-17 | 주노 쎄러퓨티크스 인코퍼레이티드 | Ｂ-세포 성숙 항원을 표적화하는 키메라 항원 수용체로 조작된 세포 요법 관련 방법 및 용도 |
| MX2022013393A (es) * | 2020-04-24 | 2023-02-14 | Memorial Sloan Kettering Cancer Center | Receptores de antígenos quiméricos dirigidos a cd19 y uso de los mismos. |
| AR122014A1 (es) * | 2020-05-06 | 2022-08-03 | Crispr Therapeutics Ag | Receptor de antígenos quimérico enmascarado específico para la proteína tirosina cinasa de tipo 7 (ptk7) y células inmunitarias que expresan el mismo |
| US11919944B2 (en) | 2020-05-11 | 2024-03-05 | Augmenta Biosciences, Inc. | Antibodies for SARS-CoV-2 and uses thereof |
| CN116490208A (zh) * | 2020-08-06 | 2023-07-25 | 史坦利科西斯治疗有限责任公司 | Il-8抗体及其使用方法 |
| CN116997345A (zh) * | 2020-12-02 | 2023-11-03 | 上海赛比曼生物科技有限公司 | 靶向bcma的嵌合抗原受体 |
| WO2022170126A2 (en) * | 2021-02-05 | 2022-08-11 | Adagio Therapeutics, Inc. | Compounds specific to coronavirus s protein and uses thereof |
| CN115491358B (zh) * | 2021-06-17 | 2024-09-06 | 复星凯特生物科技有限公司 | 一种靶向b7-h3和folr1双打靶点car t的制备及应用 |
| KR20240099224A (ko) * | 2021-09-29 | 2024-06-28 | 모덱스 테라퓨틱스, 인크. | 항원 결합 폴리펩티드, 항원 결합 폴리펩티드 복합체 및 이의 사용 방법 |
| US20230310605A1 (en) | 2021-10-28 | 2023-10-05 | Lyell Immunopharma, Inc. | Methods for culturing cells expressing ror1-binding protein |
| CN114106199B (zh) * | 2021-11-19 | 2022-07-12 | 广州百暨基因科技有限公司 | 靶向adgre2的嵌合抗原受体及其应用 |
| AU2023231766A1 (en) * | 2022-03-07 | 2024-10-17 | Medimmune Llc | Treatment methods using ctla-4 and pd-1 bispecific antibodies |
| WO2023175069A1 (en) * | 2022-03-16 | 2023-09-21 | Medigene Immunotherapies Gmbh | Tcr constant region pairing library for pramevld tcrs |
| WO2023175070A1 (en) * | 2022-03-16 | 2023-09-21 | Medigene Immunotherapies Gmbh | Tcr constant region pairing library |
| GB202208119D0 (en) * | 2022-06-01 | 2022-07-13 | Univ Oslo Hf | Anti-steap1 car |
| WO2024064958A1 (en) | 2022-09-23 | 2024-03-28 | Lyell Immunopharma, Inc. | Methods for culturing nr4a-deficient cells |
| WO2024064952A1 (en) | 2022-09-23 | 2024-03-28 | Lyell Immunopharma, Inc. | Methods for culturing nr4a-deficient cells overexpressing c-jun |
| WO2024077174A1 (en) | 2022-10-05 | 2024-04-11 | Lyell Immunopharma, Inc. | Methods for culturing nr4a-deficient cells |
| WO2024136899A1 (en) * | 2022-12-21 | 2024-06-27 | Synthorx, Inc. | Cancer therapy with il-2 conjugates and chimeric antigen receptor therapies |
| GB202301421D0 (en) * | 2023-02-01 | 2023-03-15 | Univ Oslo Hf | Switch receptor for use in adoptive cell therapy |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2389443B1 (en) * | 2009-01-23 | 2018-11-14 | Roger Williams Hospital | Retroviral vectors encoding multiple highly homologous non-viral polypeptides and the use of same |
| WO2013033626A2 (en) * | 2011-08-31 | 2013-03-07 | Trustees Of Dartmouth College | Nkp30 receptor targeted therapeutics |
| WO2015158671A1 (en) * | 2014-04-14 | 2015-10-22 | Cellectis | Bcma (cd269) specific chimeric antigen receptors for cancer immunotherapy |
| MX2017001011A (es) * | 2014-07-21 | 2018-05-28 | Novartis Ag | Tratamiento de cancer de usando un receptor quimerico de antigeno anti-bcma. |
| WO2016174852A1 (ja) * | 2015-04-30 | 2016-11-03 | 株式会社デンソー | 蒸発器 |
| KR20180021137A (ko) * | 2015-06-25 | 2018-02-28 | 아이셀 진 테라퓨틱스 엘엘씨 | 키메라 항원 수용체 (car), 조성물 및 이의 사용 방법 |
| SG10201913247XA (en) * | 2015-10-23 | 2020-02-27 | Eureka Therapeutics Inc | Antibody/t-cell receptor chimeric constructs and uses thereof |
| KR20230148844A (ko) * | 2016-03-29 | 2023-10-25 | 유니버시티 오브 써던 캘리포니아 | 암을 표적하는 키메라 항원 수용체 |
| CA3044682A1 (en) * | 2016-12-02 | 2018-06-07 | University Of Southern California | Synthetic immune receptors and methods of use thereof |
-
2019
- 2019-06-01 WO PCT/US2019/035096 patent/WO2019232503A1/en active Application Filing
- 2019-06-01 EP EP19811044.7A patent/EP3802822A4/en active Pending
- 2019-06-01 US US15/734,203 patent/US20210137977A1/en active Pending
- 2019-06-01 BR BR112020024246-2A patent/BR112020024246A2/pt unknown
- 2019-06-01 AU AU2019279084A patent/AU2019279084A1/en active Pending
- 2019-06-01 KR KR1020207038038A patent/KR20210057705A/ko unknown
- 2019-06-01 SG SG11202011837UA patent/SG11202011837UA/en unknown
- 2019-06-01 JP JP2020566230A patent/JP2021525509A/ja active Pending
- 2019-06-01 CN CN201980049331.5A patent/CN113286879A/zh active Pending
- 2019-06-01 MX MX2020012927A patent/MX2020012927A/es unknown
- 2019-06-01 EA EA202092945A patent/EA202092945A1/ru unknown
- 2019-06-01 CA CA3101510A patent/CA3101510A1/en active Pending
- 2019-06-03 TW TW108119201A patent/TW202018083A/zh unknown
-
2020
- 2020-11-26 ZA ZA2020/07393A patent/ZA202007393B/en unknown
- 2020-11-30 IL IL279100A patent/IL279100A/en unknown
- 2020-12-29 CO CONC2020/0016586A patent/CO2020016586A2/es unknown
-
2024
- 2024-03-14 JP JP2024039934A patent/JP2024073564A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2019232503A5 (ko) | ||
| JP2021500861A5 (ko) | ||
| JP2020500530A5 (ko) | ||
| JP7487112B2 (ja) | Ｃｄ１９指向性キメラ抗原受容体および免疫療法におけるその使用 | |
| WO2021129559A1 (zh) | T细胞受体融合蛋白及其用途 | |
| JPWO2021188599A5 (ko) | ||
| WO2018121605A1 (zh) | 一种多功能蛋白质 | |
| CN113227379A (zh) | 多功能多靶向嵌合抗原受体（car）系统及其使用方法 | |
| JP2020517263A5 (ko) | ||
| IL297514A (en) | Vectors and methods for in vivo transduction | |
| JP2024519335A (ja) | がん免疫療法のための投薬レジメン | |
| US20230390392A1 (en) | Multiplex gene edited cells for cd70-directed cancer immunotherapy | |
| US20230028399A1 (en) | Bcma-directed cellular immunotherapy compositions and methods | |
| GB2623191A (en) | Engineered chimeric fusion protein compositions and methods of use thereof | |
| JPWO2021203046A5 (ko) | ||
| WO2023241141A1 (zh) | 靶向ccr8的嵌合抗原受体及其用途 | |
| WO2023207390A1 (zh) | 一种ciita基因被敲除的工程化免疫细胞及其用途 | |
| JPWO2021231505A5 (ko) | ||
| WO2023083003A1 (zh) | 工程化免疫细胞及其用途 | |
| WO2023051361A1 (zh) | 工程化免疫细胞及其用途 | |
| WO2023071811A1 (zh) | 工程化免疫细胞及其用途 | |
| JPWO2022093310A5 (ko) | ||
| JPWO2020223571A5 (ko) | ||
| JP2023531064A (ja) | 癌治療の方法及び組成物 | |
| JP2024526324A (ja) | Ｂｃｍａ指向性細胞免疫療法の組成物および方法 |